YOLFTbeta
68

Shanghai MicroPort EV MedTech Co. Ltd. A

688351 · SHG · Healthcare / Medical Devices

17.70CNY-0.04 (-0.23%)

Price History

Full chart

Market Stats

Previous Close17.74
Open17.77
Day Range17.60 – 18.49
52-Week Range16.38 – 28.24
Volume4.32M
Market Cap8.03B
P/E (TTM)142.17
Forward P/E0.00
EPS0.12
Dividend Yield0.12%
Beta-0.32
50-Day Avg18.92
200-Day Avg22.51

About

Shanghai MicroPort EP MedTech Co., Ltd. engages in the research, development, production, and sale of medical devices in the field of electrophysiological interventional diagnosis and ablation therapy in China and internationally. The company offers cardiac ablation catheters, diagnostic catheters, and system navigational solutions; access conventional solutions; cryoablation solutions; and robotic magnetic navigation solutions. It also exports its products to France, Italy, Bulgaria, Brazil, and Thailand. The company was formerly known as Shanghai Wei Chuang Electrophysiology Medical Technology Co., Ltd. and changed its name to Shanghai MicroPort EP MedTech Co., Ltd. in April 2016. Shanghai MicroPort EP MedTech Co., Ltd. was founded in 2010 and is based in Shanghai, the People's Republic of China.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMs. Li Chen
  • Employees568
  • HeadquartersNo. 1-28, Lane 588, Shanghai, China, 201318, China
  • Websitehttps://www.everpace.com

Leadership

  • Ms. Li ChenDeputy General Manager of Frozen Marketing · b. 1978
  • Ms. Yan ChenSupply Chain Deputy General Manager · b. 1983
  • Mr. Yi Yong SunGM & Director · b. 1973
  • Ms. Yu ZhuDeputy GM of Finance & Secretary · b. 1975
  • Zhen Yu WuAccounting Department Director
  • Ms. Liu Ping ShenDeputy General Manager of Business Development & Project Management · b. 1983

Financials

Income Statement

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue-141.29M190.03M260.32M329.19M413.17M464.53M
Growth (%)--+34.50%+36.99%+26.46%+25.51%+12.43%
Cost of Revenue-38.70M52.39M80.43M120.12M170.52M195.22M
Gross Profit-102.58M137.64M179.90M209.08M242.65M269.31M
Gross Margin-72.61%72.43%69.11%63.51%58.73%57.97%
Operating Expense-98.73M152.61M186.11M227.83M207.27M230.29M
Operating Income-3.86M-14.98M-6.21M-18.75M35.38M39.02M
Operating Margin-2.73%-7.88%-2.38%-5.70%8.56%8.40%
EBITDA---21.00M35.74M90.39M88.00M
EBITDA Margin---8.07%10.86%21.88%18.94%
Net Income-5.74M-11.97M3.07M5.69M52.07M51.08M
Net Income Margin-4.06%-6.30%1.18%1.73%12.60%11.00%
R&D-40.85M63.01M76.93M91.31M77.40M64.08M
R&D as % of Total Revenue-28.91%33.16%29.55%27.74%18.73%13.79%
Interest Expense502.22K-463.15K718.74K1.27M886.73K300.08K
Interest Expense % of Total Revenue--0.24%0.28%0.39%0.21%0.06%

Balance Sheet

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets-646.30M668.85M1.79B1.82B1.89B1.99B
Total Liabilities-67.73M79.21M116.85M138.21M151.95M190.96M
Total Equity-578.57M589.63M1.68B1.69B1.74B1.80B
Cash-445.74M430.28M584.89M265.53M269.11M276.52M

Cash Flow

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-8.71M20.69M-9.38M-37.97M67.33M90.90M
Capital Expenditure031.18M36.71M31.93M41.93M43.82M122.23M
Free Cash Flow--22.48M-16.02M-41.31M-79.90M23.52M-31.33M
Dividends Paid975.40K------
FCF to OCF--258.07%-77.41%440.32%210.42%34.92%-34.47%

Earnings

Report DateOct 26, 2022Feb 17, 2023Apr 21, 2023
EPS Estimate---
EPS Actual0.000.00-0.02
Surprise---
TimingAfter-hoursPre-marketAfter-hours

Key Statistics & Ratios

Market Cap8.03B
Enterprise Value7.20B
Trailing P/E142.17
Forward P/E0.00
Price / Sales15.56
Price / Book4.65
EPS0.12
Book Value3.85
Revenue (TTM)516.03M
Gross Profit (TTM)284.03M
EBITDA42.08M
Profit Margin11.34%
Operating Margin2.59%
Return on Equity3.26%
Return on Assets0.29%
Shares Outstanding470.60M
Shares Float115.09M
Beta-0.32
Dividend Yield0.12%
Dividend Rate0.02
Payout Ratio16.89%

Dividends

20261×
0.02Jun 12, 2026